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ABSTRACT 
Inflammation in hemodialysis patients occurs since before undergoing hemodialysis. Inflammation is associated with an 
increase in oxidative stress. Hemodialysis patients are at risk for macronutrients and micronutrients deficiencies which can 
influence the increase in oxidative stress and inflammation. The purpose of this study was to evaluate the intake of 
micronutrients and inflammatory status in hemodialysis patients. This study was a cross-sectional study with  
76 hemodialysis patients (40 male and 36 female) who attended in two hemodialysis centers of Kendal, Indonesia. After 
obtaining the written consent, then patients were interviewed food intake consisting of macronutrient and micronutrient 
intake. Macronutrient and micronutrient intake are obtained by the semi quantitative food frequency method and classified 
as a deficit (<100% adequacy level) and normal/ more (≥100% adequacy level), according to specific recommendations for 
individuals undergoing dialysis. Serum albumin was examined using the Brom Cresol Purple (BCP) method with a low 
category (<3.5 mg.dL-1) and normal (3.5 – 4.5 mg.dL-1). The hs-CRP serum was examined using the ELISA method and 
categorized as low (<1 mg.L-1), moderate (1 – 3 mg.L-1) and high (> 3 mg.L-1). A descriptive analysis was performed. The 
results of this study showed that 88.2% deficit energy intake, 84.2% deficit protein intake, 85.5% deficit of vitamin A intake, 
85.5% deficit of vitamin C intake, 100% deficit of vitamin E intake, 98, 7% deficit zinc intake , 92.1% deficit copper intake. 
63.2% subjects are low level of serum albumin and 61.8% subjects is high level of hs-CRP serum. Macronutrient and 
micronutrient intake in most hemodialysis patients shows deficit. The serum albumin of most hemodialysis patients shows 
low level. Serum hs-CRP most hemodialysis patients show high level. 
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INTRODUCTION 
 End stage renal disease patients have high mortality rates 
which are not only caused by traditional risk factors of 
cardiovascular disease, but other factors such as 
inflammation and protein energy malnutrition (PEM) 
(Kalantar and Kopple., 2001). End stage renal disease is 
characterized by a decrease in irreversible kidney function 
with a glomerular filtration rate below 15/mL/min/1.73 m2 
and must undergo renal replacement therapy (Hill et al., 
2016). A continuous decrease in glomerular filtration rate 
will worsen the condition of chronic kidney disease (CKD) 
patients and will increase their mortality (Panichi et al., 
2008). Hemodialysis patients will experience inflammation 
that occurs since before undergoing hemodialysis 
(Kalantar et al., 2004). Yao et al. (2009) stated that 
oxidative stress will affect the occurrence of inflammation 
in hemodialysis patients. Oxidative stress in CKD patients 
occurs early in the disease and increases gradually with the 
development of kidney disorders (Yao et al., 2009). 
Hemodialysis patients will experience an increase in 
proinflammatory cytokines such as elevated serum hs-CRP 
(Verhave et al., 2005; Panichi et al., 2008). The hs-CRP 
serum is part of the process of atherosclerosis and has a 
direct effect on endothelial cells, monocyte-macrophages 
and smooth muscle cells and supports the occurrence of 
atherogenenesis (Stevinkel et al., 2005). Hemodialysis 
patients will also experience increased levels of urea which 
results in the occurrence of uremia. Urea levels in the blood 
will cause feelings of nausea and vomiting (Kalantar et al., 
2004). This will cause a decrease in appetite that can reduce 
nutrient intake. This in turn will cause nutrient intake to also 
decrease. Hemodialysis patients will also have poor eating 
behaviour such as high sugar, fat, low cereal, fruit and 
vegetables (Lou et al., 2007). Hemodialysis patients had 
lower calorie, protein, and fiber intakes than 
recommendations (Bossola et al., 2013). Decreased 
macronutrient intake will be in line with a decrease in 
micronutrient intake. Low micronutrient intake will also 
cause antioxidant intake to decrease. Antioxidants play a 
role in reducing oxidative stress (Sahni et al., 2012). High 
oxidative stress in hemodialysis patients indicates 
inflammation and will increase cardiovascular 
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complications, mortality and increase the need for 
antioxidants (Miura et al., 2002; Locatelli et al., 2002). 
Antioxidants in food ingredients are found in various active 
ingredients including vitamins C, E, pro-vitamin A, zinc, 
cooper, selenium, α-tocopherol, organosulfur, flavonoids, 
thymoquinone, statins, niacin, phycocyanin, etc. (Sahni et 
al., 2012). Vegetables and fruits contain a lot of 
antioxidants, but hemodialysis patients sometimes limit 
vegetables and fruits because of high potassium. Whereas a 
diet high in fruits and vegetables is not only good for 
improving lipid profiles, but also reduces oxidative stress 
and inflammation (Bossola et al., 2013). Hemodialysis 
patients will overhydrate and protein loss through urine and 
dialysate which can result in a decrease in albumin (Gama 
et al., 2012). Low albumin is associated with increased lipid 
peroxidation and supports oxidative stress in hemodialysis 
patients (Castro et al., 2014). Kaysen et al. (2002) states 
that low serum albumin in dialysis patients is strongly 
associated with inflammation. The aim of this study is to 
evaluate the intake of macronutrients, micronutrients and 
inflammatory status in hemodialysis patients. 
  
Scientific hypothesis 
 We investigate several hypotheses in our study: 
a. The intake of macronutrients (energy and protein of 
hemodialysis patients shows inadequacy 
b. The intake of micronutrients (vit A, C, E, zinc, 
copper) of hemodialysis patients shows inadequacy 
c. Albumin levels of hemodialysis patients show low 
levels 
d. The levels of hs-CRP hemodialysis patients show 
high levels 
 
MATERIAL AND METHODOLOGY 
 This research is a descriptive study with a cross sectional 
approach conducted from March to April 2019 in two 
hemodialysis centers in the city of Indonesia state. The 
study population was all patients undergoing outpatient care 
in two hemodialysis centers. Research subjects were all 
patients with chronic kidney disease undergoing 
hemodialysis at two hemodialysis centers were taken by 
consecutive sampling and obtained as many as 76 people. 
Inclusion criteria are hemodialysis patients who are aware 
and can communicate well and are willing to participate in 
research by signing an informed consent. Exclusion criteria 
were chronic kidney disease patients who have never 
undergone hemodialysis and patients who had sepsis. 
 The size of the sample with a confidence level (α) of 95%, 
a proportion of 13.4%, a degree of error of 10% so the 
minimum number of samples is 45 subjects. Samples who 
participated in this study were 76 people. This research has 
obtained ethics from the Ethics Research Commission of the 
Faculty of Medicine, Diponegoro University Semarang 
number 55/EC/FK UNDIP/II/2019. 
 The variables studied included macronutrient intake 
(which consists of energy, protein), micronutrient intake 
(which consists of vitamins A, C, E zinc, copper), serum 
albumin and hs-CRP serum. The research tool used was a 
semi quantitative food frequency questionnaire. Before 
dialysis, the patients’ height and weight were measured with 
a health scale, respectively. All measurements are carried 
out according to standard instructions when the subject is 
not wearing heavy clothes and no shoes. The weight and 
heights were recorded with accuracy of 100 g and 1 cm, 
respectively. Ideal body weight is used to calculate 
nutritional requirements according to recommendations for 
patients undergoing hemodialysis. This study was 
conducted by researchers assisted by an enumerator who is 
a nutritionist. Blood sampling is performed by nurses on 
duty in the hemodialysis unit before the research subjects 
conduct the hemodialysis process. Serum albumin 
concentration was measured by using the Brom Cresol 
Purple (BCP) method. Hs-CRP concentrations were 
measured with enzyme-linked immunosorbent assay 
(ELISA) kits (DRG International Inc, USA). Serum 
albumin is divided into two criteria: low (<3.5 mg.dL-1) and 
normal (3.5 – 4.5 mg.dL-1). Inflammatory status of serum 
hs-CRP is divided into three namely low risk (<1 mg.L-1), 
moderate (1 – 3 mg.L-1), high (>3 mg.L-1) (Myers et al., 
2004). The level of sufficient energy, protein, vitamins A, 
C, zinc and copper was obtained by interviewing food 
intake using a semiquantitative food frequency 
questionnaire. The data obtained is processed by performing 
a recapitulation of the frequency of the use of types of food 
and converted into grams and then processed using the 
nutrisurvey program. The adequacy levels of energy, 
protein, vitamins A, C, E, zinc and cooper are obtained by 
calculating the percentage of total intake divided by dietary 
requirement individual (DRI). Adequacy levels are 
categorized into deficits (<100% DRI) and normal / more 
(≥100% DRI).  
 
Statistic analysis 
 Data were analysed using the version 16.0 of Stastitical 
Package for the Social Sciences (SPSS). Data distribution 
and normality were seen using the Kolmogorov Smirnov 
test (p ≥0.05). A. descriptive analysis of each variable was 
carried out in which the categorical variables were 
expressed as frequencies and percentages and the 
continuous variables as mean and standard deviation or 
median (min – max). Result were expressed as mean ±SD 
(for normally distributed data) otherwise it expressed as 
median(min – max). 
 
RESULTS AND DISCUSSION 
 This research was carried out on 76 subjects consisting of 
52.6% men and 47.4% women. Hemodialysis patients are 
mostly male because the average glomerular filtration rate 
(GFR) and serum creatinine values in men are higher than 
those in female (Hecking et al., 2014). The mean age of 
hemodialysis patient was 49.12 years, with the highest 
percentage (34.2%) at age 45 – 54 years followed by age 55 
– 64 years (26.3%). Hemodialysis patients after the age of 
40 the kidney will progressively decrease the glomerular 
filtration rate (Kalantar and Kopple, 2001).  
Age more fourthy years there will be a decrease of ±10% 
the number of functional nephrons every ten years after 
patients aged 40 years due to nephrosclerosis and 
glomerulosclerosis. As a result of nephrosclerosis and 
glomerulosclerosis will cause elderly patients experiencing 
chronic kidney failure and must be treated hemodialysis. 
Hemodialysis patients have a high prevalence of 
comorbidities (Sarnak et al., 2003).  
 In this study the most common comorbid is hypertension 
(53.9%) and followed by cardiovascular disease (31.6%).  
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The kidney damage especially the cortex will stimulate the 
production of the hormone renin which will encourage 
increased blood pressure resulting in hypertension (Sarnak 
et al., 2003). 
 This study shows that 44.7% of study subjects had two 
comorbidities. Steven et al. (2010) states that the more 
comorbid hemodialysis patients have will affect physical 
function. This study shows that patients who have more than 
one comorbid have difficulty breathing problems, edema, 
lack of balance, difficulty walking, restlessness, using a 
wheelchair.  
 Hemodialysis is a kidney replacement therapy which is 
done 2 – 3 times a week with a length of 4 – 5 hours, which 
aims to remove the remnants of protein metabolism and 
correct disruption of fluid and electrolyte balance 
(Daugirdas et al., 2015). In this study 88.2% did 
hemodialysis twice a week and 12.8% once a week. Despite 
hemodialysis, not all uremic toxins can be excreted. This 
can lead to various kinds of comorbidities.  
 Hemodialysis on schedule will reduce the accumulation of 
toxins. In this study the frequency of hemodialysis subjects 
was determined by the doctor and in accordance with 
kidney damage experienced. So, it will reduce nausea and 
increase appetite. At the time of the study there were one 
subject who did not keep the hemodialysis schedule due to 
being busy, so the subjects felt very nauseous, edema and 
have difficulty breathing problems.  
 Subjects of this study had undergone hemodialysis with 
different lengths of hemodialysis. The highest percentage is 
12 months (44.7%) with a time span of 1 – 105 months. 
Kalantar and Kopple (2001) says that the provision of 
dialysis therapy in terminal kidney failure patients aims to 
prolong life and control uremia symptoms and maintain 
quality of life. Hemodialysis patients have experienced 
chronic inflammation since not undergoing hemodialysis 
(Panichi et al., 2008). Hemodialysis patients will 
experience an increase in free radical production and lipid 
peroxidation which in turn will increase inflammation 
(Bianchi, 2009). Dietary macronutrients and micronutrients 
may be especially important in protecting against human 
diseases associated with free radical damage to cellular 
DNA, lipids, and proteins (Barakat et al., 2017).  
 Kolmogorov Smirnov test shows that the adequacy level 
of protein and zinc is normally distributed because of  
p-values ≥0.05. While the adequacy level of energy, 
vitamins A, C, E and zinc shows data not normally 
distributed as indicated by p <0.05. Table 2 compares 
macronutrients and micronutrient intake with 
recommendations for hemodialysis patients. As It was seen 
that the intake of macronutrients and micronutrients in most 
hemodialysis patients is deficit. This research shows that 
88.2% of the subjects experienced a deficit of energy and 
84.2% deficit of protein.  Macronutrient and micronutrient 
intake is very important to prevent the occurrence of protein 
energy malnutrition (PEM) that often occurs in 
hemodialysis patients (Kalantar and Kopple, 2001). PEM 
is the state of decreased body pools of protein with or 
without fat depletion or a state of diminished functional 
capacity, caused at least partly by inadequate nutrient intake 
relative to nutrient demand and/or which is improved by 
nutritional repletion.  
 Indicators of PEM in maintenance hemodialysis patients 
include decreased dietary protein and energy intake. In this 
study there were 57.9% of subjects showed nausea so that 
food intake decreased, and nutritional adequacy was not 
fulfilled. The subject said that nausea made it difficult to 
accept food. The patient limits the protein to prevent 
increased in creatinine urea serum. PEM are associated with 
chronic inflammation (Kalantar and Kopple, 2001). PEM 
in hemodialysis patients not only shows deficit of energy 
and protein. But it also deficit micronutrients that the body 
needs (Kalantar and Kopple, 2001). This research shows 
there is a deficit of micronutrients needed by hemodialysis 
patients such as vitamins A, C, E, zinc and copper. Slee 
(2012) state about hemodialysis patients will experience a 
phase called anorexia cachexia syndrome (ACS). 
 Table 1 Characteristics of hemodialysis patients. 
Characteristics (n = 76) n (%) Mean ±SD 
Gender 
Male 
Female 
 
40 (52.6) 
36 (47.4) 
 
 
Age (years) 
25-34 
35-44 
45-54 
55-64 
65-74 
 
6 (7.9) 
20 (26.3) 
26 (34.2) 
20 (26.3) 
4(5.3) 
49.12 ±10.03* 
Comorbid 
Hypertension 
Diabetes 
Cardiovascular disease 
Serebrovascular disease 
Gastrointestinal disease 
Tuberculosis 
 
41 (53.9) 
6 (7.9) 
24 (31.6) 
3 (3.9) 
1 (1.3) 
1 (1.3) 
 
The number of comorbid 
1 comorbid 
>1 comorbid 
>2 comorbid 
>3 comorbid 
 
32 (42.1) 
34 (44.7) 
9 (11.8) 
1 (1.3) 
 
Frequency hemodialysis 
One per week 
Two per week 
 
9 (11.8) 
67 (88.2) 
 
Time of hemodialysis 
(months) 
< 6 months 
6 – 12 months 
>12 months 
 
26 (34.2) 
16 (21.1) 
34 (44.7) 
10 (1 – 105)** 
Note: * Mean ±Standar deviation; ** Median (minimum– 
maximum). 
 
 Table 2. Kolmogorof smirnov test 
Variable p 
Adequacy level of Energy 0.048 
Adequacy level of Protein 0.175* 
Adequacy level of Vitamin A 0.000 
Adequacy level of Vitamin C 0.000 
Adequacy level of Vitamin E 0.000 
Adequacy level of Zink 0.200* 
Adequacy level of Copper 0.001 
Note : *p-value ≥0.05 = normally distributed data. 
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ACS is a collection of symptoms characterized by 
decreased appetite (anorexia) and increased resting energy 
expenditure (REE) accompanied by increased protein 
breakdown. Hemodialysis patients will also experience 
catabolism so that they need more calories than healthy 
people. Patients undergoing hemodialysis will usually 
experience an increase in uremic toxins that can reduce 
appetite and even loss of appetite due to nausea. Decreased 
appetite occurs because of an increase in proinflammatory 
cytokines and their effects peripherally on the skeletal 
muscle pathway that regulates turnover protein and 
centrally on the neurons in the hypothalamus that regulate 
appetite. ACS causes a negative energy balance in 
hemodialysis patients due to decreased food intake. 
Increased proinflammatory cytokines will increase the 
development of ACS, so that the activity of leptin and 
ghrellin may be disrupted. Leptin is anoxygenic peptide 
which can reduce appetite, while ghrellin is orexigenic 
peptide which increases appetite. Both are pathways 
regulating appetite in the brain/hypothalamus. In the normal 
pathway, neurons in the hypothalamus center produce 
melanocortins (proopiomelanocortin (POMC)/ cocaine and 
amphetamine-regulated transcript (CART)) activated by 
leptin, which have anorexic and catabolic effects. Whereas 
neuronpeptide Y (NPY) and angouti-related protein (AgRP) 
express neurons activated by ghrellin which have 
orexigenic effects. In hemodialysis patients, there is a 
disturbance in the circulation of leptin and ghrellin where 
the POMC/CART activity remains while the NPY/AgRP 
decreases. This has an impact on increasing resting energy 
expenditure and decreasing appetite. Besides that, the 
increase in creatinine urea also has the effect of reducing 
appetite. Decreased appetite is what will cause decreased 
food intake. Barakat et al. (2017); Therrien, Byham and 
Beto (2015) shows the same thing that hemodialysis 
patients are at risk of nutrient deficiency due to nutrient 
intake under the recommendation of KDOQI. Table 2 
shows that the intake of vitamin A most (85.5%) of 
respondents showed a deficit. Sahni et al., (2012) shows 
that vitamin A intake in hemodialysis patients lower than 
healthy control groups . This study also showed that the 
median level of vitamin A adequacy was 41.95% with a 
minimum value of 1.2% and a maximum of 143.7 %. A 
range that is too far away indicates that there are study 
subjects who have very low and very high levels of 
sufficiency. According to KDOQI, the need for vitamin A 
in CKD patients with hemodialysis is 900 µg in males and 
700 µg in females. Food sources that contain lots of vitamin 
A include all kinds of milk, butter, eggs, fish oil, vegetables 
with green and yellow leaves, fruits and liver (Kalantar 
and Fouque, 2017). Subjects with deficit intake of vitamin 
A said they were afraid to eat vegetables and fruit because 
they thought it was high in potassium so they worried that 
blood potassium would increase. The study subjects only 
ate 1 – 2 tablespoons of vegetables each meal. Vitamin A is 
mostly contained in green and orange vegetables and fruits. 
Green vegetables and orange fruits are usually high in 
potassium which is automatically reduced by hemodialysis 
patients (Bossola et al., 2014). The study subjects also did 
not consume liver containing high vitamin A. Vas et al. 
(2014) stated that the intake of vitamin A was only 373.98 
(257.57 – 649.50) mcg from 700 to 900 mcg recommended. 
This shows a deficit intake vitamin A in hemodialysis 
patients. Vas et al. (2014) showed that 81.4% of subjects 
had inadequate vitamin A intake. This research also shows 
that most 85.5% had a sufficient level of vitamin C deficit. 
Barakat et al. (2017) which states that vitamin C intake in 
hemodialysis patients usually tends to be low because of the 
 Table 2 Intake macronutrients and micronutrients  in hemodialysis patient. 
Variables N (%) Average ±SD Recomendation2 
Energy    
Deficite 67 (88.2) 60.95 (28.5 – 128.3)** 30 – 35 kcal/kg bw/day (≥60 year) 
Normal/ Higher 9 (11.8)  35 kcal/kgbw/day (<60 year) 
Protein    
Deficite 64 (84.2) 69.36 ±30.3564* 1.2 gr/kgbw/day 
Normal/ Higher 12 (15.8)   
Vitamin A    
Deficite 65 (85.5) 41.95 (1.2 – 143.7)** ≥900 µg/day (male) 
Normal/ Higher 11 (14.5)  ≥700 µg/day(female) 
Vitamin C    
Deficite 65 (85.5) 42.4 (4.8 – 150.3)** 90 mg/day (male) 
Normal/ Higher 11 (14.5)  75 mg/day (female) 
Vitamin E    
Deficite 76 (100) 18.35 (2 – 64)** 15 mg/day 
Normal/ Higher - -  
Zink     
Deficite 75 (98.7) 34.637 ±17.305* ≥10 mg/day (male) 
Normal/ Higher 1 (1.3)  ≥8 mg/day (female) 
Cooper    
Deficite 70 (92.1) 53.3 (6.7 – 166.7)** 1.5 mg/day 
Normal/ Higher 6 (7.9)   
Note:* Mean ±standar deviation; ** Median (min-max). 
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limitation of potassium in diets recommended for 
hemodialysis patients. Hemodialysis patients restrict 
vegetables and fruit for fear of increasing potassium. 
Kalantar and Kopple (2001) states that hemodialysis 
patients have significantly lower intakes of vitamin C, fiber, 
potassium and carotenoids than healthy people. The Dietary 
Reference Intake Panel of the Institute of Medicine 
recommends a recommended vitamin C diet of 90 mg per 
day for men and 75 mg per day for women (Kalantar and 
Fouque, 2017). The inadequacy of vitamin C in this study 
was due to the fact that most of the subjects thought that 
vegetables and fruits contained lots of potassium and should 
be avoided. Adequacy levels of vitamin E in study subjects 
showed that 100% had a deficit. Kooshki, Samadipour 
and Akbarzadeh (2015) points out the same thing that 
vitamin E intake is less than the recommendation. Vitamin 
E is found in many grains. Lou et al. (2007) said that 
hemodialysis patients also limit potassium intake by 
avoiding vegetables, fruit and seeds. The subject of this 
study also conducted restrictions on grains. This will cause 
the intake of vitamin E is also not enough to meet nutritional 
needs. Based on interviews with research subjects, they 
limited their intake of legumes such as tofu, tempeh, peas, 
green beans, cashews for fear of creatinine urea increasing. 
The need for Vitamin E in both male and female CKD 
patients is 15 mg/day (Kalantar and Fouque, 2017). 
Sources of vitamin E are vegetable oils, unprocessed grains, 
nuts, fruits, vegetables and meat (Kopple, 2001). Most of 
the research subjects (98.7%) had a zinc adequacy level 
classified as deficit. Sahni et al., (2012) states that the 
average zinc intake was found to be less than the 
recommendation for hemodialysis patients. Sahni et al. 
(2012) states that zinc is a mineral that has strong potential 
as an antioxidant, usually obtained from foods rich in 
protein. Low protein intake is significantly correlated with 
low zinc intake. The low zinc intake in the study subjects 
was due to the protein intake of the subjects also showing a 
deficit with the average protein intake of 69.361 ±30.356%. 
Zinc is found in many foods such as meat, fish, cheese, 
chicken, eggs and milk products, beans, almonds and 
parsley. This research shows that copper adequacy level 
was mostly (92.1%) indicating a deficit. Szpanowska, 
Chowaniec and Kolarzyk (2008) stated that copper intake 
was very low, less than 40% of the  recommended. This 
research subjects carried out a restriction in their diet, 
especially those containing protein for fear that their 
creatinine urea had increased. Graph 1 shows that most 
(63.2%) had a relatively low albumin because it was less 
than 3.5 g.dL-1. Low serum albumin is a sign of protein 
energy malnutrition. Protein energy malnutrition when 
energy and protein requirements are not met as needed. 
Deficit of food intake in hemodialysis patients in the long 
run will cause protein energy malnutrition. Low protein 
intake will cause hypoalbuminemia (Kaysen et al., 2002). 
This study shows that the intake of macronutrients and 
micronutrients in most subjects is deficit. The origin of 
PEM appears to precede dialysis treatment, and it is 
engendered progressively as glomerular filtration rate 
(GFR) decreases to less than 55 mg.min-1 (Kalantar and 
Kopple, 2001). Hypoalbuminemia have been shown to 
develop along with the progression of CKD stages. Serum 
albumin will decrease with decreasing glomerular filtration 
rate (GFR). Hemodialysis patients show a decrease in 
glomerular filtration rate up to <15 mL/min/1.72m2. Serum 
albumin is a negative acute phase reactant as a marker of 
inflammation (Kaysen et al., 2002). Graph 2 shows that 
most (61.8%) subjects had serum hs-CRP in the high-risk 
category because it was more than 3 mg.L-1. Based on 
recommendations from the Centers for Disease Control and 
Prevention (CDC) cut offs point hs-CRP levels  
>3 mg.L-1 indicate a group at high risk of cardiovascular 
disease (Myers et al., 2004).  
 This study also found that the median hs-CRP level was 
4.85 mg.L-1 with a minimum level of 0.29 mg.L-1 and a 
maximum of 20.30 mg.L-1. Increased levels of CRP as a 
consequence of the chronic inflammatory process that is 
found in conditions such as kidney disorders. The 
inflammatory process in hemodialysis is caused by the 
involvement of various factors such as accumulation of 
uremia toxin, malnutrition, oxidative stress, volume 
overload, carbonyl stress, decreased levels of antioxidant, 
low production of anti-inflammatory cytokines, comorbid, 
dialysis treatment (Kalantar et al., 2003). Hemodialysis 
patients often experience a condition of uremia. Uremia in 
hemodialysis patients will increase proinflammatory 
cytokine levels associated with increased mortality. In 
addition, the dialysis process also contributes to the increase 
in cytokine secretion at the end of hemodialysis. In this case, 
 
Figure 1 Frequency serum albumin level.   Figure 2 Frequency serum hs-CRP level. 
 
. 
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the dialysis membrane can stimulate increased cytokine 
release. Increased proinflammatory cytokines can reduce 
appetite so that food intake decreases (Kalantar et al., 
2003). Decreased food intake such as energy and protein are 
likely to cause PEM which will increase inflammation by 
increasing hs-CRP levels. In this study the majority of 
hemodialysis patients showed micronutrient intake that was 
classified as deficit. vitamins A, C, E, zinc, copper are 
micronutrients that act as antioxidants. Malnourished 
dialysis patients may be deficient of antioxidant such as 
vitamin C or carotenoids which may lead to increased 
oxidative stress leading to inflammation (Kalantar and 
Kopple, 2001). Antioxidants are very important to protect 
the body from free radical attack which can increase 
oxidative stress. Increased lipid peroxidation (LP) and 
reduced enzymatic antioxidant defence have been observed 
in predialysis patients. Loss or deficiency of antioxidant 
activity could also contribute to enhanced oxidative stress 
in uremia (Kalantar et al., 2003; Tarko et al., 2013). 
Oxidative stress defines an imbalance between formation of 
reactive oxygen species (ROS) and anti-oxidative defence 
mechanisms. It occurs when there is excessive free radical 
production and/or low antioxidant defence and results in 
chemical alterations of bio-molecules, causing structural 
and functional modifications (Sahni et al., 2012). Oxidative 
stress and inflammation status are well-known interrelated 
factors in hemodialysis patient with common underlying 
mechanisms including endothelial dysfunction and 
common complications, such as cardiovascular disease and 
death (Bianchi, 2009). Serum hs-CRP is an inflammatory 
marker that is associated with an increased risk of death due 
to cardiovascular disorders (Stevinkel et al., 2005).  
 
CONCLUSION 
 This study shows that intake of macronutrients and 
micronutrients in hemodialysis patients is deficit. This 
research concludes that 88.2% deficit of energy and 84.2% 
deficit of protein. In addition, micronutrient intake also 
shows 85.5% deficit of vitamin A, 85.5% deficit of vitamin 
C, 100% deficit of vitamin E. Zinc intake at 98.7% showed 
a deficit and copper intake at 92.1% also showed a deficit. 
There were 63.2% of subjects had low albumin serum and 
61.8% of subjects had high hs-CRP serum.  
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